Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Blood Transfusion, Autologous clinical trials

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Blood Transfusion, Autologous: 1 US clinical trial tracked, none currently recruiting.

Blood Transfusion, Autologous is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Massachusetts General Hospital, running 1 of these trials.

Enrollment posture brief

Registry condition blood-transfusion-autologous

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Blood Transfusion, Autol (th…0%
Open-enrollment share among volume-matched conditions near Blood Transfusion, Autologous

Blood Transfusion, Autologous has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Blood Transfusion, Autologous on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Blood Transfusion, Autologous is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Blood Transfusion, Autologous records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Red blood Cells auto-transfusion Procedure
1 trials

US sites by state

Facility locations filed on Blood Transfusion, Autologous trials. A trial with sites in several states counts in each.

Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Blood Transfusion, Autologous page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Blood Transfusion, Autologous trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Massachusetts General Hospital sponsors the most Blood Transfusion, Autologous trials on record, review their full trial history before evaluating a specific study. See Massachusetts General Hospital's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Blood Transfusion, Autologous condition card totals 1 registered trials; most-linked intervention Red blood Cells auto-transfusion; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.